AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

Before you orderOffer from Amazon

Get workout gear delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

A meta-analysis of 21 studies found that patient navigation and patient or clinician reminders were associated with more follow-up colonoscopies after positive FIT or FOBT screening results. Across intervention groups, 69.1% completed colonoscopy, compared with 47.8% in control groups—still below the recommended 80% target.

A meta-analysis of 21 studies found that patient navigation and reminders for patients or clinicians were associated with higher rates of follow-up colonoscopy after a positive stool-based colorectal cancer screening test. Still, just 69.1% of patients in intervention groups completed colonoscopy, below the 80% target cited by the U.S. Multi-Society Task Force on Colorectal Cancer.

The review, led by Michael Pignone of Duke University School of Medicine and colleagues, examined interventions for people with an abnormal fecal immunochemical test (FIT) or fecal occult blood test (FOBT). Pooled results showed colonoscopy completion of 69.1% in intervention groups versus 47.8% in control groups. The authors reported higher completion with patient-level interventions overall (risk ratio 1.28, 95% confidence interval 1.17-1.41) and system-level interventions (risk ratio 1.45, 95% CI 1.19-1.76).

Among individual approaches, patient navigation had the highest reported completion rate, at 72.5%. Rates were 67.7% with patient reminders, 65.7% with clinician reminders and 60.2% with automated referral to a gastrointestinal consultation. The researchers reported that individual interventions were associated with relative increases in completion, but comparisons across approaches should be read cautiously: study designs and results varied, and few studies directly compared interventions against one another.

The analysis included 19,613 patients across 21 interventional studies, 11 randomized and 10 nonrandomized. Fifteen studies were conducted in the United States; the rest took place in the United Kingdom, Italy, Malaysia, South Korea, China and Israel. The study appeared in JAMA Internal Medicine. The researchers said further work is needed to assess the added value of combining interventions and their cost-effectiveness.

At a glance
reportWhen: Reported October 12, 2026
The developmentA meta-analysis published in JAMA Internal Medicine found that navigation and reminder interventions increased colonoscopy completion after positive stool-based colorectal cancer screening, but rates remained below the recommended target.

Closing the Follow-Up Gap

A stool-based screening test is a two-step process when the result is positive: patients need follow-up colonoscopy to complete the screening pathway. The review’s results suggest that reminders and navigation can help more people reach that next step, but the gap between observed completion and the 80% target remains substantial.

The finding matters because a positive stool test is not, by itself, a completed screening episode. The source report notes that people with positive results are the group at higher risk for advanced adenomas or early-stage colorectal cancer, while previous studies have found that only about half go on to colonoscopy. The meta-analysis does not establish why any one patient misses follow-up, but it supports the use of practical supports to improve completion.

Amazon

patient navigation for colonoscopy

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

How Stool-Test Follow-Up Works

The U.S. Preventive Services Task Force and the American Cancer Society recommend colorectal cancer screening for average-risk adults beginning at age 45, using colonoscopy or other established methods such as FIT or FOBT. About nine in 10 people undergoing a fecal screening test have a negative result, according to the source report. A positive result calls for follow-up colonoscopy rather than ending the screening process.

Prior research cited in the report has identified possible barriers including poorly coordinated care, staffing constraints, health literacy, patient concerns and fear of a cancer diagnosis. These are potential obstacles described in earlier work, not explanations proven for every participant in the studies. The review assessed interventions intended to address patient or health-system barriers, rather than testing the diagnostic accuracy of stool tests.

“Pooled data suggest that 69.1% of patients in intervention groups completed follow-up colonoscopy after an abnormal FIT/FOBT result, compared with 47.8% in control groups.”

— Michael Pignone and co-authors

Limits of the Intervention Evidence

The findings show that interventions were associated with improved completion, but they do not identify one approach as best for every clinic. The studies differed in design and had moderate to high heterogeneity in some analyses. The review also included nonrandomized studies, which can be more susceptible to bias, although the researchers reported no difference in intervention effects between randomized and nonrandomized study groups.

The editorialists noted that few studies directly compared interventions and that newer stool-based tests such as FIT-DNA were not included. The source material does not specify which specific reminders or navigation methods work best for different patient groups, nor whether combining approaches would reliably raise completion to 80%. The reported rates are pooled study results and should not be treated as a prediction for every health system.

Testing Strategies in Clinics

The immediate implication from the editorialists is for clinics and clinical leaders to choose a follow-up approach that fits local staffing, capacity and priorities. Navigation and reminder systems are supported by the review as ways to raise completion, but the analysis does not prescribe a single model.

Further studies are needed to compare strategies directly, measure the added effect of combining them and assess costs. Until that evidence is available, the central measure to watch is whether health systems can move completion closer to the 80% target after positive stool tests. The source report does not give a timeline for new studies or a specific next policy decision.

Key Questions

What did the meta-analysis find?

Across the included studies, 69.1% of patients in intervention groups completed follow-up colonoscopy, compared with 47.8% in control groups. The interventions included patient navigation, reminders and automated referrals.

Which approach had the highest reported completion rate?

Patient navigation had the highest reported completion rate among the listed individual interventions, at 72.5%. The studies were not all direct comparisons, so the figures do not prove it is the best option in every setting.

Why is colonoscopy needed after a positive FIT or FOBT?

A positive stool-based screening result requires follow-up colonoscopy to complete the two-step screening process. The stool test result alone does not complete that follow-up.

No. The pooled completion rate in intervention groups was 69.1%, below the 80% target cited by the U.S. Multi-Society Task Force on Colorectal Cancer.

What remains unknown?

The review does not establish which intervention works best across different clinics, whether combined strategies offer extra benefit or which options are most cost-effective. The editorialists also noted that newer FIT-DNA tests were not represented in the studies they reviewed.

Source: rss

Wellness content on this site is informational and not a substitute for professional medical guidance.
HALLOWEEN

Halloween Picks

As an affiliate, we earn on qualifying purchases.

You May Also Like

A common vitamin could help fight one of the deadliest brain cancers

New research suggests a common vitamin may support treatment efforts for glioblastoma, one of the most aggressive brain cancers.

Cancer Center Surges In Global Coverage

Cancer Center’s international media mentions increase significantly, indicating rising global attention and influence.

Ebola and hantavirus can start like the flu but turn deadly fast

Ebola and hantavirus infections may initially resemble the flu but can escalate quickly to life-threatening conditions, health officials warn.

From Hyper-Independent To Human: Learning How To Accept Help

A growing trend shows individuals shifting from extreme independence to embracing support, reflecting changing attitudes towards vulnerability and mental health.